Bacillus Calmette-Guerin versus Mitomycin C for the Treatment of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: The Debate Continues

Sylvester, Richard J.

doi:10.1016/j.eururo.2009.04.043

Bacillus Calmette-Guerin versus Mitomycin C for the Treatment of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: The Debate Continues

Sylvester, Richard J.

(2009) European Urology — Vol. 56, n° 2, p. 266-268 (2009)

Files

pdfdocument.pdf

Restricted Access
Adobe PDF
90.64 KB

Request a copy

Details

Authors

Sylvester, Richard J.
Author

Affiliations

UCLouvain

Citations

APA
Chicago
FWB

Sylvester, R. J. (2009). Bacillus Calmette-Guerin versus Mitomycin C for the Treatment of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: The Debate Continues. European Urology, 56(2), 266-268. https://doi.org/10.1016/j.eururo.2009.04.043 (Original work published 2009)